
Benner has built his career around a single problem: people who are prescribed medicines often do not take them as intended, and health plans pay for the consequences.
Josh Benner is founder and CEO of RxAnte, which helps health plans improve how members use their medicines through analytics and a value-based pharmacy service. He came to the company after research and policy work on medication adherence.
From Pharmacy Research to Health Policy
Benner earned a Doctor of Pharmacy from Drake University and a Doctor of Science in health policy and management from the Harvard School of Public Health. He completed a postdoctoral fellowship in health services research at Brigham and Women’s Hospital.
He was a principal at ValueMedics Research and, after IMS Health bought that firm in 2007, served as global lead for medication adherence at IMS. He later became a fellow and managing director at the Brookings Institution’s Engelberg Center for Health Care Reform, focusing on medical technology policy.
Building RxAnte
RxAnte’s team page describes Benner as founder and CEO, and credits his research with shedding new light on nonadherence and promising ways to improve it. The company applies predictive analytics to find members at risk and pairs that work with Mosaic, its home pharmacy service.
In the January 2026 Primus Capital investment announcement, Benner said “pharmacy care needs to be more individualized and coordinated than ever before.” He also sits on the Health Policy and Management Executive Council at the Harvard T.H. Chan School of Public Health and is an Entrepreneur in Residence at the Harvard i-lab.